Laboratoire Noreva-Led

Name

Laboratoire Noreva-Led

Legal name

NOREVA

Website

https://noreva-laboratoires.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Dermo-Cosmetic Skincare

NAICS

Cosmetics, Beauty Supplies, and Perfume Retailers (456120), Health and Personal Care Retailers (4561)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF), Sensitive Skin & Barrier Repair (CRABAAAG)

Keywords

• Dermo-cosmetic skincare
• Dermatological skincare products
• Anti-pigmentation skincare
• Atopic skincare treatments
• Pharmacy skincare brands

Headquarters

HQ city

Clermont-ferrand

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Direct-to-Consumer E-commerce: Noreva sells products directly to consumers through its owned e-commerce website (noreva-laboratoires.com). Revenue is generated through one-time product purchases at listed retail prices, with promotional seasonal discounts (e.g., -15% summer sale code ETE26, -40% on selected products). Consumer spending thresholds unlock free samples and free products.
2. Pharmacy and Parapharmacy Distribution: Noreva distributes its full product range through partner pharmacies and parapharmacies across France and internationally. The pharmacy channel serves as the primary sales avenue, with a store locator on the website. Revenue flows through wholesale relationships with pharmacy chains and independent pharmacies.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Laboratoire Noreva-Led develops, manufactures, and markets a comprehensive portfolio of dermatologist-developed dermo-cosmetic skincare products organized across 19 specialized sub-brands (e.g., TRIO WHITE MÉLA, ECZEANE, SENSIDIANE, EXFOLIAC, BERGASOL). The range addresses hyperpigmentation, atopic/eczema-prone skin, sensitive/reactive skin, acne, sun protection, anti-aging, psoriasis, seborrheic dermatitis, stretch marks, and scalp/hair conditions, sold primarily through pharmacies and the company's direct-to-consumer e-commerce website.

Product overview

Laboratoire Noreva-Led is a French dermatological skincare company offering a comprehensive portfolio of dermo-cosmetic products organized into 19 distinct sub-brands addressing specific skin conditions and concerns. The product portfolio spans hyperpigmentation (TRIO WHITE® MÉLA), atopic/eczema-prone skin (ECZEANE®), sensitive skin (SENSIDIANE®, ACTIPUR®), acne-prone skin (EXFOLIAC®), sun protection (BERGASOL®), anti-aging (ALPHA KM®+, NOVEANE® PREMIUM, IKLEN®+), and specialized categories including rosacea (SENSIDIANE® AR+), scarring (CICADIANE®), dehydration (AQUAREVA®), very dry skin (XERODIANE® CERA+), fragile skin (DENSIDIANE®), psoriasis (PSORIANE®), seborrheic dermatitis (SEBODIANE DS®), stretch marks (STRIVADIANE®), foot care (EPIDIANE®), deodorants (DEOLIANE®), and scalp/hair (HEXAPHANE®). Products are available through pharmacies and the company's e-commerce platform, with formulations developed by dermatologists emphasizing high tolerance, clean dermatology, and clinically tested efficacy. The company operates as a unified brand with multiple specialized sub-brands rather than a platform-plus-modules architecture.

Differentiator

Problem solved

Functional benefit

Brands

• BERGASOL: Sun protection products for skin exposed to sun
• AQUAREVA
• XERODIANE CERA+
• ECZEANE
• ACTIPUR
• EXFOLIAC
• SENSIDIANE
• SENSIDIANE AR+
• CICADIANE
• ALPHA KM+
• NOVEANE PREMIUM
• IKLEN+
• DENSIDIANE
• TRIO WHITE MÉLA
• PSORIANE
• SEBODIANE DS
• STRIVADIANE
• EPIDIANE
• DEOLIANE
• HEXAPHANE

Products and services

• TRIO WHITE MÉLA Range
• ECZEANE Crème relipidante anti-grattage 48h
• ECZEANE Brume relipidante anti-grattage 48h
• BERGASOL Sun Protection Range
• SENSIDIANE Range
• EXFOLIAC Range
• AQUAREVA Range
• XERODIANE CERA+ Range
• ACTIPUR Range
• ALPHA KM+ Range
• NOVEANE PREMIUM Range
• IKLEN+ [Pure-C-Reverse] Range
• CICADIANE Range
• DENSIDIANE Range
• PSORIANE Range
• SEBODIANE DS Range
• STRIVADIANE Range
• EPIDIANE Range
• DEOLIANE Range
• HEXAPHANE Range

Quantifiable outcome

• TRIO WHITE MÉLA routine: -38% reduction in spot intensity and -24% reduction in spot size (clinical evaluation by dermatologist, 50 volunteers, serum + SPF50+ day care over 56 days)
• +7 more outcomes

Named customers5 records

Segments7 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Partner Pharmacies (France)coreChannel Partner/ Reseller/ DistributorNoreva's core distribution channel is through partner pharmacies across France and internationally. The company maintains an online pharmacy locator on its website and invites pharmacies to join as official resellers. Pharmacists serve as the primary in-person advisors recommending Noreva products to consumers. The brand positions its pharmacy network as a key trust signal and competitive differentiator, with all products available 'en pharmacie'.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Vichy: L'Oréal-owned dermo-cosmetic brand distributed via French pharmacies with mineralizing water positioning and ranges (Liftactiv, Neovadiol) that overlap with Noreva's anti-aging and sensitive skin SKUs.
• Avène: Pierre Fabre-owned dermo-cosmetic brand sold in French pharmacies, with strong positioning in sensitive skin and atopic care (Pédiatril, Tolerance Extreme lines) — overlapping directly with Noreva's SENSIDIANE and ECZEANE ranges.
• A-Derma: Pierre Fabre's plant-based dermo-cosmetic brand focused on fragile and atopic skin (Exomega). Directly comparable to Noreva's ECZEANE and CICADIANE ranges and shared pharmacy distribution model.
• Uriage: Puig-owned thermal-water dermo-cosmetic brand sold in French pharmacies, with a comparable portfolio of condition-specific ranges (Xémose, Roséliane, Depiderm) targeting eczema, rosacea, and hyperpigmentation — direct overlap with Noreva.
• SVR Laboratoires: Independent French dermo-cosmetic laboratory sold through pharmacies, with comparable clinical positioning and high-actives formulations (Topialyse, Sebiaclear). Closest peer in size profile and dermatology-led narrative to Noreva.
• Ducray: Pierre Fabre dermo-cosmetic brand with strong franchises in hair/scalp and dermatological skincare (Anaphase, Keracnyl, Melascreen). Overlaps with Noreva's HEXAPHANE, ACTIPUR/EXFOLIAC, and TRIO WHITE MÉLA ranges.
• Bioderma: NAOS-owned French dermo-cosmetic brand with a strong pharmacy presence and condition-specific ranges (Sensibio, Atoderm, Photoderm) that directly compete with Noreva's sensitive, eczema, and sun sub-brands.

Broad incumbents

• Eucerin: Beiersdorf-owned dermo-cosmetic brand with pharmacy distribution and clinically validated ranges (AtopiControl, Anti-Pigment) overlapping with Noreva's atopic and hyperpigmentation offerings, though typically positioned slightly more medical than dermatology-luxury.
• CeraVe: L'Oréal-owned skincare brand built on ceramides and clinical efficacy, with growing presence in French pharmacies. Competes with Noreva's barrier-restoration products (ECZEANE, XERODIANE) and benefits from significantly larger global marketing spend.
• La Roche-Posay: L'Oréal-owned dermatological skincare brand sold primarily in pharmacies globally. Directly comparable to Noreva in distribution channel, dermatology positioning, and condition-led product ranges, but operates at materially greater global scale and R&D budget.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/noreva.laboratoires
• Instagraminstagram.com/noreva_officiel
• TikToktiktok.com/tag/noreva?lang=fr
• LinkedInlinkedin.com/company/noreva-pharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratoire Noreva-Led